Professional Documents
Culture Documents
2017
[PRODUCTS (By Devices, Consumables, Management
Softwares and Servicing); APPLICATION (Diagnostic,
Therapeutic, Research and others); END-USERS (Hospitals,
Diagnostic Laboratories, Academic & Research
Laboratories, Blood & Blood Components Bank,
Ambulatory surgical centers and Others); GEOGRAPHY
(North America, Europe, Asia-Pacific and Rest of the
World)]
– Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
–Forecast to 2023
Abliance France
Americord U.S.
APEL Co Japan
Avalun France
Barkey Germany
–Forecast to 2023
Biobase Germany
BioE U.S.
Biomerieux France
Bioplus India
Biosigma Italy
Biotec U.K.
Bulgin U.S.
–Forecast to 2023
Copan Italy
Diagast France
Diagon Hungary
Dialab Austria
Diconex Argentina
Elecktro-mag Turkey
Euroclinic Italy
Evermed S R L Italy
–Forecast to 2023
Fiocchetti Italy
Genrui China
Google U.S.
Haemonetics U.S.
Haier China
Hamilton U.S.
Heska U.S.
–Forecast to 2023
Hetech Italy
Hidemar Spain
HTL-Strefa Poland
HTZ U.K.
Immoclinic Spain
Infomed Switzerland
IT Synergistics U.S.
Jiangsu Huida Medical Instruments Co
China
Ltd
JMS Corporation U.S.
Labcold U.S.
–Forecast to 2023
LifeScan U.S.
MacoPharma U.S.
Medtronic U.S.
Microculus U.S.
–Forecast to 2023
Panasonic Japan
Plastilab Lebanon
PZ Cormay Poland
R.S.Scientific Italy
Robonik India
Sanquin Netherlands
–Forecast to 2023
Sarstedt Germany
Spinreact Spain
Stago France
Stratasys U.S.
–Forecast to 2023
Tritec Germany
Visiomed France
–Forecast to 2023
1 EXECUTIVE SUMMARY
Blood is a vital fluid of human body plays a major role in saving the life of a patient during the
life threatening situations by a procedure called transfusion. But before transfusion, the
blood collected from the donor needs to be checked thoroughly to avoid the chances of
spreading the infectious diseases like HIV/AIDS, Hepatitis and others, hence different types
of collection, processing devices & consumables are used to analyze the blood samples and
then segregate them into different blood components like plasma, platelets, WBC’s and
RBC’s to treat the patient lacking in particular blood component or whole blood.
Management tools are part of blood market that plays a major role in managing the blood
supply chain till the point of transfusion. This blood collection, processing, management
devices & consumables are mainly used in diagnostics and therapeutic procedures to save
the life of a patient and enhance their safety.
According to IQ4I analysis, the blood collection, processing, management devices &
consumables global market is estimated to reach $35,693 million by 2023. Increase in aging
population and subsequent rise in incidence of chronic diseases, emergence of automated
blood collection and processing devices, favourable reimbursement policies are some of the
factors driving the blood collection, processing management devices & consumables market
growth. Emergence of needle free devices & RFID technology and market expansion
opportunities in emerging countries are few opportunities for the BCPMD&C market.
However, patient safety risks due to chances of transmission of infections and infectious
diseases and lack of skilled professionals in handling automated processing devices are
expected to hamper the market growth.
The blood collection, processing, management devices & consumables global market is
mainly segmented by applications, products, end-users and by geography. The BCPMD&C
global market by the application is segmented into diagnostics, therapeutics, research and
others. The diagnostic segment accounted for the largest share in 2016. Among the various
types of diagnostics application segment, non-infectious disease segment has been gaining
huge momentum with strong CAGR from 2016-2023. Among the therapeutic application
segment, injury, trauma and surgery generated the largest revenue in 2016 due to
increasing trauma and accident incidences.
–Forecast to 2023
End-Users are further segmented into hospitals, diagnostic laboratories, academic institutes
& research laboratories, blood & blood component banks, ambulatory surgical centers and
others (clinics and biotech & biopharma companies). Among the end users of the
BCPMD&C market hospitals are expected to grow at high CAGR from 2016-2023 due to
availability of wide range of collection, processing, managing tools which enhances patient
safety thus driving the market growth rate.
Matured regions such as North America commanded the largest market share of XX% in
2016 due to high investments in healthcare infrastructures, availability of government funds
improved market growth in this region. However, Asia-pacific region is expected to grow at
the highest CAGR of XX% from 2016-2023 due to increased healthcare awareness,
improved economic growth, and increasing awareness among the people about the spread
of infectious diseases through blood as a main medium. Significant launch of new products,
–Forecast to 2023
agreement, partnership, collaborations, and joint ventures are the industry trends that are
playing a major role in the market growth.
As the market is fragmented, various key players like Abbott Laboratories (U.S.), Becton,
Dickinson & Company (U.S.), Haemonetics Corporation (U.S.), Fresenius Kabi (U.K.),
Terumo Corporation (Japan) holds a share of XX% in blood collection, processing,
management devices & consumables market and remaining XX% of the market is occupied
by others players. Emerging players of this market includes Hamilton (U.S.), FL Medical
(Italy), Beurer GmbH (Germany), Greiner Bio-One (Germany), Vision Scientific (Korea),
Magellan (U.S.), LifeScan (U.S.), Sekisui Medical Co., Ltd (Japan), SuZhou Hybiome
Biomedical Engineering Co. Ltd (China), Quotient (U.S), Diagast (France), Infomed
(Switzerland), Yancheng Cordial Co Ltd (China), Arteriocyte (U.S.), VOGT Medical
(Germany), JMS Corporation (U.S.), Innvol Medical Systems (India), Kawasumi Laboratories
Inc (Japan).
Major players in blood collection, processing, management devices & consumables global
market include Abbott Laboratories (U.S.), Becton, Dickinson & Company (U.S.),
Haemonetics Corporation (U.S.), Grifols International S.A. (Spain), Sysmex Corporation
(Japan), Immucor, Inc. (U.S.), Danaher Corporation (U.S.), Fresenius Kabi (U.K.), Terumo
Corporation (Japan), Macopharma (France), ThermoFisher Scientific Corporation (U.S.),
Biomerieux (France), Bio-Rad Laboratories (U.S.) and Roche Holdings AG (Switzerland).
–Forecast to 2023
FIGURE 1
40000
Represents CAGR % (2016-2023)
35000
XX%
30000
Market Size ($Mn)
XX%
25000
20000 XX%
15000
10000
XX%
5000
0
2015 2016 2017 2018 2019 2020 2021 2022 2023
North America Europe Asia-Pacific RoW
–Forecast to 2023
FIGURE 2
25,000
20,000
Market Size ($Mn)
15,000
10,000
5,000
-
Servicing Management By devices Consumables
softwares
2016 2023
–Forecast to 2023
FIGURE 3
4,500
4,000
Market Size ($Mn)
3,500
3,000
2,500
2,000
1,500
1,000
500
-
2016 2023
FIGURE 4
5,000
4,500
4,000
Market Size ($Mn)
3,500
3,000
2,500
2,000
1,500
1,000
500
-
2016 2023
–Forecast to 2023
FIGURE 5
2016 2023
–Forecast to 2023
FIGURE 6
14,000
12,000
Market Size ($Mn)
10,000
8,000
6,000
4,000
2,000
-
Others Ambulatorly Academic & Blood & Diagnostic Hospitals
surgical research blood
centers components
bank
2016 2023
–Forecast to 2023
5 MARKET ANALYSIS
Advanced automated blood collection and processing devices are considered as one of the
recent advancements in market since it has resolved the problem of contamination and
medical complications leading to life threatening conditions. These devices eliminate the
manual operational challenges associated with autologous blood collection and whole blood
processing. Compared to traditional manual devices, these devices provide enhanced
efficiency, features and patient safety. Automated devices often reduce the medical errors
usually done by healthcare professionals during the blood collection and processing
procedures, thus decreasing the time consumption of the particular steps and human
interpretation with assured quality, maximum safety and efficiency while ensuring optimal
functionality and ease of use.
Use of automation can help to reduce the errors and consequently the use of these
automated devices has become a strategic element in improving patient safety. REVOS and
TACSI systems by Terumo Corporation (Japan), Minicare I-20 blood system by Philips
(Netherlands), MacoPress Smart Cord blood processing system by MacoPharma (U.S.) are
some of the automated blood collection & processing devices offered by the market players.
But with all these advantages automated devices and their related equipments are not yet
widely used as they are expensive and are used more in developed countries. Thus posing
an opportunity to the growth of the market.
–Forecast to 2023
FIGURE 7
Abbott Laboratories, accounted for the share of XX% of blood collection, processing,
management devices & consumables global market. This is one of the fastest growing
healthcare companies focusing mainly on maintaining balanced product portfolio, leadership
product categories aligned with healthcare trends, and innovation in transformational
technologies. The company holds acquisitions to bolster its offerings and its geographic
presence which is the major factor for their increasing revenue. Abbott offers automated
next-generation blood processing products such as Abbott PRISMnEXT, high blood volume
screening instrument with Chemiluminescent Immunoassay (ChLIA) technology, which is
designed to perform blood screening test ensuring patient safety. The future plans of the
company include development of advanced system versions along with customer focused
solutions.
–Forecast to 2023
6 INTRODUCTION
The research on blood collection, processing, management devices & consumables market
involved both widespread secondary and primary research. The secondary research was
carried out on company websites, annual reports, SEC filings, articles, press releases,
journals and paid sources to identify and collect both the qualitative and quantitative data
related to BCPMD&C market. The primary sources were experts from supply side such as
CEOs, directors, international/regional marketing managers, & marketing executives and
from demand side such as hospitals, blood & blood component banks and purchase
managers. All the primary sources were interviewed to acquire and verify critical qualitative
& quantitative information and also to assess the future forecast of the all segments of the
blood collection, processing, management devices & consumables market. Along with these
the additional information extracted was about the key players in this industry with their
market revenues, products and developments. The factors responsible for growth and
restriction of the blood collection, processing, management devices & consumables market
along with the future opportunities were also determined through secondary research and
verified through primary sources.
The following illustrative figure shows the market research methodology applied in making
this report on the blood collection, processing, management devices & consumables global
market.
The size of the blood collection, processing, management devices & consumables global
market and its various segments and sub-segments were estimated and validated through
secondary and primary research. All the blood collection, processing, management devices
& consumables market percentage shares, splits, and breakdowns were determined using
secondary sources and verified through primary sources to get the final quantitative and
qualitative data. This data is consolidated and added with detailed inputs and analysis from
IQ4I and presented in this report.
–Forecast to 2023
FIGURE 8
Top-down & Bottom up approach was used to derive the blood collection, processing,
management devices & consumables market as well as the BCPMD&C market by
applications, products and end-users. Different percentage splits were applied for different
segments of the blood collection, processing, management devices & consumables market
as per the data derived. The market share analysis is validated by both top down and bottom
up approaches.
–Forecast to 2023
FIGURE 9
Diagnostic Europe
Therapeutic By consumables
laboratories
Academic & Asia Pacific
Research Softwares
research labs
Blood & blood Rest of the World
Others Servicing
component banks
Ambulatory
surgical centers
Others
–Forecast to 2023
6.1.2 ASSUMPTIONS
Parameter Assumptions
–Forecast to 2023
Disclaimer: IQ4I strategic analysis services are limited publications containing valuable
market information provided to a select group of customers in response to orders. Our
customers acknowledge, when ordering, that IQ4I strategic analysis services are for our
customers’ internal use and not for general publication or disclosure to third parties.
Quantitative market information is based primarily on interviews and therefore, is subject to
fluctuation.
IQ4I does not endorse any vendor, product or service depicted in its research publications.
IQ4I strategic analysis publications consist of the opinions of IQ4I' research and should not
be construed as statements of fact. IQ4I disclaims all warranties, expressed or implied, with
respect to this research, including any warranties of merchantability or fitness for a particular
purpose.
All trademarks, copyrights and other forms of intellectual property belong to their respective
owners and may be protected by copyright. Under no circumstance may any of these be
reproduced in any form without the prior written agreement of their owner.
No part of this strategic analysis service may be given, lent, resold or disclosed to non-
customers without written permission.
Reproduction and/or transmission in any form and by any means including photocopying,
mechanical, electronic, recording or otherwise, without the permission of the publisher is
prohibited.
Email: bd@IQ4I.com